Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Graefen

Showing results (591-600 of 850) with videos related to

Pageof 85
Sort By:
Oncotarget|April 1, 2015
HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomyCristina Villares Zabalza, Meike Adam, Christoph Burdelski, et al.
Prostate Cancer and Prostatic Diseases|June 11, 2024
Nerve-sparing radical prostatectomy using the neurovascular structure-adjacent frozen-section examination (NeuroSAFE): results after 20 years of experienceFrancesca Ambrosini, Felix Preisser, Derya Tilki, et al.
Annals of Surgical Oncology|December 25, 2012
Effect of nodal metastases on cancer-specific mortality after cytoreductive nephrectomyQuoc-Dien Trinh, Shyam Sukumar, Jan Schmitges, et al.
Cancer Management and Research|December 7, 2018
Upregulation of centromere protein F is linked to aggressive prostate cancersCosima Göbel, Cansu Özden, Cornelia Schroeder, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 5, 2020
Prostate Cancer Grade and Stage Misclassification in Active Surveillance Candidates: Black Versus White PatientsLara Franziska Stolzenbach, Giuseppe Rosiello, Angela Pecoraro, et al.
Urologic Oncology|September 20, 2020
Comparison of Mexican-American vs Caucasian prostate cancer active surveillance candidatesClaudia Collà Ruvolo, Lara Franziska Stolzenbach, Luigi Nocera, et al.
Central European Journal of Urology|August 8, 2022
Diabetes mellitus lowers the chance of short-term urinary continence recovery in prostate cancer patients undergoing radical prostatectomyAlexander Philippi, Philipp Mandel, Jan L Hohenhorst, et al.
Current Urology|January 30, 2023
Differences in rates of pelvic lymph node dissection in National Comprehensive Cancer Network favorable, unfavorable intermediate- and high-risk prostate cancer across United States SEER registriesRocco Simone Flammia, Benedikt Hoeh, Francesco Chierigo, et al.
The Journal of Urology|August 23, 2019
Effect of Extended Pelvic Lymph Node Dissection on Oncologic Outcomes in Patients with D'Amico Intermediate and High Risk Prostate Cancer Treated with Radical Prostatectomy: A Multi-Institutional StudyFelix Preisser, Roderick C N van den Bergh, Giorgio Gandaglia, et al.
World Journal of Urology|March 3, 2007
Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2-10 ng/ml in 4,480 menCarsten Stephan, Chuanliang Xu, Henning Cammann, et al.
Pageof 85

Showing results (591-600 of 850) with videos related to

Sort By:
Pageof 85
Oncotarget|April 1, 2015
HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomyCristina Villares Zabalza, Meike Adam, Christoph Burdelski, et al.
Prostate Cancer and Prostatic Diseases|June 11, 2024
Nerve-sparing radical prostatectomy using the neurovascular structure-adjacent frozen-section examination (NeuroSAFE): results after 20 years of experienceFrancesca Ambrosini, Felix Preisser, Derya Tilki, et al.
Annals of Surgical Oncology|December 25, 2012
Effect of nodal metastases on cancer-specific mortality after cytoreductive nephrectomyQuoc-Dien Trinh, Shyam Sukumar, Jan Schmitges, et al.
Cancer Management and Research|December 7, 2018
Upregulation of centromere protein F is linked to aggressive prostate cancersCosima Göbel, Cansu Özden, Cornelia Schroeder, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 5, 2020
Prostate Cancer Grade and Stage Misclassification in Active Surveillance Candidates: Black Versus White PatientsLara Franziska Stolzenbach, Giuseppe Rosiello, Angela Pecoraro, et al.
Urologic Oncology|September 20, 2020
Comparison of Mexican-American vs Caucasian prostate cancer active surveillance candidatesClaudia Collà Ruvolo, Lara Franziska Stolzenbach, Luigi Nocera, et al.
Central European Journal of Urology|August 8, 2022
Diabetes mellitus lowers the chance of short-term urinary continence recovery in prostate cancer patients undergoing radical prostatectomyAlexander Philippi, Philipp Mandel, Jan L Hohenhorst, et al.
Current Urology|January 30, 2023
Differences in rates of pelvic lymph node dissection in National Comprehensive Cancer Network favorable, unfavorable intermediate- and high-risk prostate cancer across United States SEER registriesRocco Simone Flammia, Benedikt Hoeh, Francesco Chierigo, et al.
The Journal of Urology|August 23, 2019
Effect of Extended Pelvic Lymph Node Dissection on Oncologic Outcomes in Patients with D'Amico Intermediate and High Risk Prostate Cancer Treated with Radical Prostatectomy: A Multi-Institutional StudyFelix Preisser, Roderick C N van den Bergh, Giorgio Gandaglia, et al.
World Journal of Urology|March 3, 2007
Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2-10 ng/ml in 4,480 menCarsten Stephan, Chuanliang Xu, Henning Cammann, et al.
Pageof 85